RecruitingPhase 2NCT07091175

Dupilumab Therapy in Nephrotic Syndrome in Children

Studying CHILD syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National University Hospital, Singapore
Principal Investigator
Hui Kim Yap
National University Hospital, Singapore
Intervention
Dupilumab(biological)
Enrollment
66 target
Eligibility
6-18 years · All sexes
Timeline
20252028

Study locations (2)

Collaborators

National Medical Research Council (NMRC), Singapore · KK Women's and Children's Hospital · National University of Singapore

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07091175 on ClinicalTrials.gov

Other trials for CHILD syndrome

Additional recruiting or active studies for the same condition.

See all trials for CHILD syndrome

← Back to all trials